INVA FY 2010 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24M-0.6% YoY

Gross Profit

$24M100.0% margin

Operating Income

-$78M-323.3% margin

Net Income

-$84M-346.2% margin

EPS (Diluted)

$-1.16

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$76M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$331M

Total Liabilities

$354M

Stockholders' Equity

-$22M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$24M	-0.6%
Gross Profit	$24M	$24M	-0.6%
Operating Income	-$78M	-$81M	+3.7%
Net Income	-$84M	-$85M	+1.7%